MiniMed Group, Inc. Common Stock (MMED) stock surged +5.30%, trading at $16.10 on NASDAQ, up from the previous close of $15.29. The stock opened at $15.49, fluctuating between $15.17 and $16.20 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 13, 2026 | 15.49 | 16.28 | 15.17 | 16.10 | 1.41M |
| Jul 10, 2026 | 15.05 | 15.37 | 14.70 | 15.29 | 832.8K |
| Jul 09, 2026 | 15.04 | 15.40 | 14.79 | 15.05 | 480.02K |
| Jul 08, 2026 | 15.29 | 15.51 | 14.76 | 15.02 | 1.06M |
| Jul 07, 2026 | 15.21 | 15.48 | 15.01 | 15.37 | 524.51K |
| Jul 06, 2026 | 15.59 | 15.85 | 15.22 | 15.29 | 1.03M |
| Jul 02, 2026 | 15.34 | 15.76 | 15.18 | 15.59 | 447.2K |
| Jul 01, 2026 | 14.87 | 15.74 | 14.87 | 15.19 | 859.71K |
| Jun 30, 2026 | 14.90 | 15.55 | 14.26 | 14.95 | 847.11K |
| Jun 29, 2026 | 14.17 | 15.13 | 14.08 | 14.88 | 1.34M |
| Jun 26, 2026 | 14.22 | 14.67 | 13.73 | 14.24 | 6.31M |
| Jun 25, 2026 | 14.25 | 14.76 | 13.94 | 14.22 | 653.12K |
| Jun 24, 2026 | 13.97 | 14.98 | 13.95 | 14.13 | 1.11M |
| Jun 23, 2026 | 14.14 | 14.49 | 13.73 | 13.74 | 537.62K |
| Jun 22, 2026 | 14.61 | 14.96 | 14.12 | 14.22 | 631.54K |
| Jun 18, 2026 | 14.39 | 14.96 | 14.17 | 14.77 | 2.86M |
| Jun 17, 2026 | 15.02 | 15.37 | 14.11 | 14.17 | 535.32K |
| Jun 16, 2026 | 15.04 | 15.36 | 14.70 | 14.70 | 438.96K |
| Jun 15, 2026 | 15.17 | 15.52 | 14.87 | 15.00 | 1.02M |
| Jun 12, 2026 | 15.37 | 15.68 | 15.00 | 15.16 | 963.03K |
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
| Employees | 0 |
| Beta | -3.63 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Healthcare |
| Industry | Medical - Equipment & Services |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep